EXACT Therapeutics AS (OSL:EXTX)

Norway · Delayed Price · Currency is NOK

0.8000

+0.1000 (14.29%)

At close: Aug 3, 2026

EXACT Therapeutics AS Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-86.97	-52.33	-48.33	-40.1	-58.59
Depreciation & Amortization	3.68	2.43	2.09	1.94	1.83
Stock-Based Compensation	2.26	2.82	3.96	-0.4	4.16
Other Adjustments	2.09	-0.52	0	-0.21	-0.52
Change in Receivables	12.69	-39.39	-1.32	-0.53	-1.62
Changes in Accounts Payable	-0.75	6.53	-0.69	5.46	0.74
Changes in Other Operating Activities	-	-0.08	0	-	-1.11
Operating Cash Flow	-66.99	-80.55	-44.3	-33.85	-55.11
Operating Cash Flow Growth	-	-	-	-	-

Investing Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-5.32	-1.51	-3.09	-0.25	-1.63
Proceeds from Sale of Investments	-	-	-	20.37	-
Other Investing Activities	2.62	0.92	0.95	0.48	0.62
Investing Cash Flow	-2.7	-0.58	-2.15	20.6	-1.01

Financing Activities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Repaid	-0.76	-0.6	-0.58	-0.51	-0.44
Net Long-Term Debt Issued (Repaid)	-0.76	-0.6	-0.58	-0.51	-0.44
Issuance of Common Stock	-	129.46	25	0.1	0.51
Net Common Stock Issued (Repurchased)	-	129.46	25	0.1	0.51
Other Financing Activities	-0.03	5.47	-1.25	-0.12	-0.12
Financing Cash Flow	-0.8	134.33	23.17	-0.53	-0.05

Net Cash Flow

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Foreign Exchange Rate Adjustments	-4.7	-0.1	0.32	0.26	-0.15
Net Cash Flow	-70.49	53.21	-23.27	-13.78	-56.17

Free Cash Flow

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-72.31	-82.05	-47.39	-34.1	-56.74
Free Cash Flow Growth	-	-	-	-	-
FCF Margin	-122559.00%	-	-1062990.00%	-7503.15%	-109106.00%
Free Cash Flow Per Share	-1.14	-2.37	-1.48	-1.14	-1.89
Levered Free Cash Flow	-90.11	-45.56	-50.6	-33.47	-59.19
Unlevered Free Cash Flow	-87.26	-45.48	-50.02	-33.17	-59.28